These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2086862)

  • 1. [Multiple insulin injection therapy as intensive insulin therapy].
    Itoh H; Namba M; Kono N; Tarui S
    Nihon Rinsho; 1990 Dec; 48 Suppl():1015-21. PubMed ID: 2086862
    [No Abstract]   [Full Text] [Related]  

  • 2. [Application and practice of intensive insulin therapy].
    Kishikawa H; Soejima H; Tamama Y; Araki E; Shichiri M
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():297-303. PubMed ID: 12387009
    [No Abstract]   [Full Text] [Related]  

  • 3. [Multiple insulin injections therapy as an intensive insulin therapy].
    Kishikawa H; Wake N; Shichiri M
    Nihon Rinsho; 1997 Nov; 55 Suppl():249-54. PubMed ID: 9434476
    [No Abstract]   [Full Text] [Related]  

  • 4. Substitution of night-time continuous subcutaneous insulin infusion therapy for bedtime NPH insulin in a multiple injection regimen improves counterregulatory hormonal responses and warning symptoms of hypoglycaemia in IDDM.
    Kanc K; Janssen MM; Keulen ET; Jacobs MA; Popp-Snijders C; Snoek FJ; Heine RJ
    Diabetologia; 1998 Mar; 41(3):322-9. PubMed ID: 9541173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Continuous subcutaneous insulin infusion].
    Ito H; Kanatsuka A
    Nihon Rinsho; 1997 Nov; 55 Suppl():267-72. PubMed ID: 9434479
    [No Abstract]   [Full Text] [Related]  

  • 6. Diabetic renal-retinal syndrome: does tight control help?
    Cowan CL
    Transplant Proc; 1987 Apr; 19(2 Suppl 2):86-9. PubMed ID: 3551259
    [No Abstract]   [Full Text] [Related]  

  • 7. [The use of continuous subcutaneous insulin infusion (CSII) with personal insulin pumps in the treatment of children and adolescents with diabetes type 1].
    Jarosz-Chobot P
    Wiad Lek; 2004; 57(5-6):263-6. PubMed ID: 15518073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients.
    Nathan DM; Dunn FL; Bruch J; McKitrick C; Larkin M; Haggan C; Lavin-Tompkins J; Norman D; Rogers D; Simon D
    Am J Med; 1996 Apr; 100(4):412-7. PubMed ID: 8610727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced incidence of hypoglycemia in diabetic dogs receiving intensive insulin therapy by implantable pump.
    Wigness BD; Rupp WM; Rohde TD; Steffes MW; Mauer SM; Dorman FD; Chapman RC; Blackshear PJ; Buchwald H
    Trans Am Soc Artif Intern Organs; 1983; 29():496-500. PubMed ID: 6369732
    [No Abstract]   [Full Text] [Related]  

  • 10. The importance of anti-insulin antibody in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusion or multiple daily insulin injections therapy.
    Sahin SB; Cetinkalp S; Ozgen AG; Saygili F; Yilmaz C
    Acta Diabetol; 2010 Dec; 47(4):325-30. PubMed ID: 20842389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Insulin therapy with pens and pumps].
    Schwedes U
    Med Klin (Munich); 1996 Feb; 91 Suppl 1():16. PubMed ID: 8839106
    [No Abstract]   [Full Text] [Related]  

  • 12. Fasting and postprandial plasma glucose and peripheral insulin levels in insulin-dependent diabetes mellitus and non-insulin-dependent diabetes mellitus subjects during continuous intraperitoneal versus subcutaneous insulin delivery.
    Hermans MP; van Ypersele de Strihou M; Ketelslegers JM; Squifflet JP; Buysschaert M
    Transplant Proc; 1995 Dec; 27(6):3329-30. PubMed ID: 8539974
    [No Abstract]   [Full Text] [Related]  

  • 13. [Dawn phenomenon. Studies using artificial pancreas in insulin dependent diabetic patients].
    Rodríguez García MA; Gutiérrez López MA; Durán García S
    Med Clin (Barc); 1988 Jun; 91(3):81-2. PubMed ID: 3050312
    [No Abstract]   [Full Text] [Related]  

  • 14. Why pumps? Continuous subcutaneous insulin infusion for children and adolescents with type 1 diabetes.
    Weintrob N; Shalitin S; Phillip M
    Isr Med Assoc J; 2004 May; 6(5):271-5. PubMed ID: 15151365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parental fear of hypoglycemia: young children treated with continuous subcutaneous insulin infusion.
    Patton SR; Dolan LM; Henry R; Powers SW
    Pediatr Diabetes; 2007 Dec; 8(6):362-8. PubMed ID: 18036061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hypoglycemic risk in IDDM].
    Grimaldi A; Bosquet F; Davidoff P; Sachon C; Digy JP; Landault C; Doumith R; Thervet F
    Journ Annu Diabetol Hotel Dieu; 1988; ():175-202. PubMed ID: 3050221
    [No Abstract]   [Full Text] [Related]  

  • 17. SHBG (sex hormone binding globulin) levels in insulin dependent diabetic patients according to the route of insulin administration.
    Lassmann-Vague V; Raccah D; Pugeat M; Bautrant D; Belicar P; Vague P
    Horm Metab Res; 1994 Sep; 26(9):436-7. PubMed ID: 7835829
    [No Abstract]   [Full Text] [Related]  

  • 18. [Intensified insulin therapy by multiple injections or by pump].
    Pernet A
    Schweiz Med Wochenschr; 1986 Jan; 116(3):77-82. PubMed ID: 3511525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New methods for subcutaneous insulin administration. A year's experience with the insulin pump and multiple insulin injection therapy].
    Dahl-Jørgensen K; Hanssen KF; Aagenaes O; Larsen S
    Tidsskr Nor Laegeforen; 1984 May; 104(13):856-61. PubMed ID: 6379982
    [No Abstract]   [Full Text] [Related]  

  • 20. Insulin pump therapy in youth with type 1 diabetes: a retrospective paired study.
    Nimri R; Weintrob N; Benzaquen H; Ofan R; Fayman G; Phillip M
    Pediatrics; 2006 Jun; 117(6):2126-31. PubMed ID: 16740856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.